Cargando…

Editorial: Reassessing Twenty Years of Vaccine Development against Tuberculosis

Detalles Bibliográficos
Autores principales:	Schaible, Ulrich E., Kaufmann, Stefan H. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808321/ https://www.ncbi.nlm.nih.gov/pubmed/29467766 http://dx.doi.org/10.3389/fimmu.2018.00180

Ejemplares similares

Vaccine development against tuberculosis before and after Covid-19
por: Kaufmann, Stefan H. E.
Publicado: (2023)

Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity
por: Schaible, Ulrich E., et al.
Publicado: (2017)

Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
por: Kaufmann, Stefan H. E.
Publicado: (2020)

The Granuloma in Tuberculosis: Dynamics of a Host–Pathogen Collusion
por: Ehlers, Stefan, et al.
Publicado: (2013)

Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of Success
por: Kaufmann, Stefan H. E.
Publicado: (2021)

Editorial: Insights in microbial immunology: 2022
por: Marriott, Ian, et al.
Publicado: (2023)

Twenty Years of AIRE
por: Perniola, Roberto
Publicado: (2018)

A Dangerous Liaison between Two Major Killers: Mycobacterium tuberculosis and HIV Target Dendritic Cells through DC-SIGN
por: Kaufmann, Stefan H.E., et al.
Publicado: (2003)

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
por: Kaufmann, Stefan H. E., et al.
Publicado: (2017)

Editorial: Recent advances in the development of vaccines against Acinetobacter baumannii
por: Khalili, Saeed, et al.
Publicado: (2023)

Designing Vaccines for the Twenty-First Century Society
por: Finco, Oretta, et al.
Publicado: (2014)

Editorial: Non-reactogenic vaccines against Q-fever
por: Gregory, Anthony E., et al.
Publicado: (2023)

Reverse Translation in Tuberculosis: Neutrophils Provide Clues for Understanding Development of Active Disease
por: Dorhoi, Anca, et al.
Publicado: (2014)

Editorial: Nanoparticle Vaccines Against Infectious Diseases
por: Reljic, Rajko, et al.
Publicado: (2019)

Correction of the Iron Overload Defect in β-2-Microglobulin Knockout Mice by Lactoferrin Abolishes Their Increased Susceptibility to Tuberculosis
por: Schaible, Ulrich E., et al.
Publicado: (2002)

Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model
por: Platteel, Anouk C. M., et al.
Publicado: (2017)

Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19
por: Gong, Wenping, et al.
Publicado: (2023)

Editorial: Beyond Th1: Novel concepts in tuberculosis vaccine immunology
por: Dijkman, Karin, et al.
Publicado: (2022)

Toward Novel Vaccines Against Tuberculosis: Current Hopes and Obstacles
por: Thaiss, Christoph A., et al.
Publicado: (2010)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
por: Nieuwenhuizen, Natalie E., et al.
Publicado: (2018)

Advances in protein subunit vaccines against tuberculosis
por: Zhang, Ying, et al.
Publicado: (2023)

Editorial: Irradiation technologies for vaccine development
por: Wijewardana, Viskam, et al.
Publicado: (2023)

Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development
por: Hu, Zhidong, et al.
Publicado: (2022)

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
por: Afkhami, Sam, et al.
Publicado: (2020)

Editorial: Why Vaccines to HIV, HCV, and Malaria Have So Far Failed—Challenges to Developing Vaccines Against Immunoregulating Pathogens
por: Li, Shuo, et al.
Publicado: (2015)

Editorial: Innovative Therapeutic and Vaccine Approaches Against Respiratory Pathogens
por: Calzas, Cynthia, et al.
Publicado: (2019)

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
por: Kaufmann, Stefan H E, et al.
Publicado: (2005)

Malnutrition and Infection: Complex Mechanisms and Global Impacts
por: Schaible, Ulrich E, et al.
Publicado: (2007)

Gene Set Enrichment Analysis Reveals Individual Variability in Host Responses in Tuberculosis Patients
por: Domaszewska, Teresa, et al.
Publicado: (2021)

Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
por: Ottenhoff, Tom H. M., et al.
Publicado: (2012)

Mycobacterium tuberculosis Invasion of the Human Lung: First Contact
por: Maertzdorf, Jeroen, et al.
Publicado: (2018)

Gut Dysbiosis Thwarts the Efficacy of Vaccine Against Mycobacterium tuberculosis
por: Nadeem, Sajid, et al.
Publicado: (2020)

Editorial: Immunological Memory to Fungal Infections and Vaccine Development
por: Nicola, André Moraes, et al.
Publicado: (2022)

Editorial: Advances in Immunotherapeutic Approaches to Tuberculosis
por: Estrada García, Iris, et al.
Publicado: (2021)

Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis
por: Negi, Kriti, et al.
Publicado: (2022)

Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application
por: Coppola, Mariateresa, et al.
Publicado: (2018)

Editorial: Mycobacterial Glycolipids—Role in Immunomodulation and Targets for Vaccine Development
por: Källenius, Gunilla, et al.
Publicado: (2020)

Editorial: Research, Development and Clinical Trials for Peptide-Based Vaccines
por: Jiang, Shisong, et al.
Publicado: (2022)

Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity
por: Patin, Emmanuel C., et al.
Publicado: (2017)

Live Vaccines Have Different NK Cells and Neutrophils Requirements for the Development of a Protective Immune Response Against Tuberculosis
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4f126smf3a8p7rut8kgf535cb9